Alpha Tau Moves Closer to FDA Clearance for Alpha DaRT
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
SEOUL, South Korea and ALISO VIEJO, Calif. – May 7, 2026 Medit Corp., a global leader in digital dentistry...
